Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Perspective on the current state of the LRRK2 field
Jean‐Marc Taymans, Matt Fell, Tim Greenamyre, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Systematic rare variant analyses identify RAB32 as a susceptibility gene for familial Parkinson’s disease
Paul J. Hop, Dongbing Lai, Pamela Keagle, et al.
Nature Genetics (2024) Vol. 56, Iss. 7, pp. 1371-1376
Open Access | Times Cited: 27
A STING–CASM–GABARAP pathway activates LRRK2 at lysosomes
Amanda Bentley‐DeSousa, Agnes Roczniak-Ferguson, Shawn M. Ferguson
The Journal of Cell Biology (2025) Vol. 224, Iss. 2
Open Access | Times Cited: 2
Autophagy in Parkinson’s Disease
Lior Nechushtai, Dan Frenkel, Ronit Pinkas‐Kramarski
Biomolecules (2023) Vol. 13, Iss. 10, pp. 1435-1435
Open Access | Times Cited: 31
Plant-derived exosomes as cell homogeneous nanoplatforms for brain biomacromolecules delivery ameliorate mitochondrial dysfunction against Parkinson’s disease
Yang Xu, Ge Yan, Jingyu Zhao, et al.
Nano Today (2024) Vol. 58, pp. 102438-102438
Closed Access | Times Cited: 13
Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases
Hossein Mousavi, Mehdi Rimaz, Behzad Zeynizadeh
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 9, pp. 1828-1881
Closed Access | Times Cited: 8
Evolving Landscape of Parkinson’s Disease Research: Challenges and Perspectives
Rumiana Koynova, Janet M. Sasso, Qiongqiong Angela Zhou
ACS Omega (2025) Vol. 10, Iss. 2, pp. 1864-1892
Open Access | Times Cited: 1
Inhibition of Parkinson’s disease–related LRRK2 by type I and type II kinase inhibitors: Activity and structures
Marta Sanz Murillo, Amalia Villagran Suarez, Verena Dederer, et al.
Science Advances (2023) Vol. 9, Iss. 48
Open Access | Times Cited: 19
The Complex Interplay between Toxic Hallmark Proteins, Calmodulin-Binding Proteins, Ion Channels, and Receptors Involved in Calcium Dyshomeostasis in Neurodegeneration
Danton H. O’Day
Biomolecules (2024) Vol. 14, Iss. 2, pp. 173-173
Open Access | Times Cited: 6
The landscape of rare genetic variation associated with inflammatory bowel disease and Parkinson’s disease comorbidity
Meltem Ece Kars, Yiming Wu, Peter D. Stenson, et al.
Genome Medicine (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 6
Perspectives of People At-Risk on Parkinson’s Prevention Research
Jessi L. Keavney, Soania Mathur, Karlin Schroeder, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 3, pp. 399-414
Open Access | Times Cited: 5
Genetic mutations in kinases: a comprehensive review on marketed inhibitors and unexplored targets in Parkinson's disease
Amir Raza, Jeevika Raina, Sanjeev Kumar Sahu, et al.
Neurological Sciences (2025)
Closed Access
The WAVE complex in developmental and adulthood brain disorders
Hyung‐Goo Kim, Clara Berdasco, Angus C. Nairn, et al.
Experimental & Molecular Medicine (2025)
Open Access
Functionally active modulators targeting the LRRK2 WD40 repeat domain identified by FRASE-bot in CACHE Challenge #1
Akhila Mettu, Marta Glavatskikh, Xiaowen Wang, et al.
Chemical Science (2025)
Open Access
NERINE reveals rare variant associations in gene networks across multiple phenotypes and implicates an SNCA-PRL-LRRK2 subnetwork in Parkinson's disease
Sumaiya Nazeen, Xinyuan Wang, Autumn Morrow, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Endogenous LRRK2 and PINK1 function in a convergent neuroprotective ciliogenesis pathway in the brain
Enrico Bagnoli, Yu‐En Lin, Sophie Burel, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 5
Open Access
Effect of LRRK2 Inhibition on the Activity of Glucocerebrosidase in Patient-Specific Cells from Patients with Gaucher Disease
Tatiana Usenko, Katerina Basharova, Anastasia Bezrukova, et al.
Biochemistry (Moscow) (2025) Vol. 90, Iss. 1, pp. 99-106
Closed Access
Parkinson’s disease and metabolic disorders, understanding their shared co-morbidity through the autonomic nervous system
Thanh Pham, Rebecca E. Schelling, Ken H. Loh
Advances in genetics (2025)
Closed Access
Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2G2019S model of Parkinson’s disease
Zachary Gaertner, Cameron Oram, Amanda Schneeweis, et al.
(2025)
Open Access
Carriers of LRRK2 pathogenic variants show a milder, anatomically distinct brain signature of Parkinson's disease
Jakub Kopál, Andrew Vo, Tao Qin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Investigating the prevalence of the G2019S mutation in Parkinson's disease among a Libyan population
Nuri Awayn, Sara A Hashish, S. A. Salem, et al.
Journal of Parkinson s Disease (2025)
Open Access
Biomarker-guided decision making in clinical drug development for neurodegenerative disorders
Jeffrey L. Cummings, Charlotte E. Teunissen, Brian Fiske, et al.
Nature Reviews Drug Discovery (2025)
Closed Access
A Personalized 14-3-3 Disease-Targeting Workflow Yields Repositioning Drug Candidates
Yonika Arum Larasati, Gonzalo P. Solis, Alexey Koval, et al.
Cells (2025) Vol. 14, Iss. 8, pp. 559-559
Open Access
In silico fragment-based discovery of CIB1-directed anti-tumor agents by FRASE-bot
Yi An, Jiwoong Lim, Marta Glavatskikh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
A STING-CASM-GABARAP Pathway Activates LRRK2 at Lysosomes
Amanda Bentley‐DeSousa, Agnes Roczniak-Ferguson, Shawn M. Ferguson
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
New therapies on the horizon: Targeted protein degradation in neuroscience
James A Gregory, Christopher M. Hickey, Juan D. Chavez, et al.
Cell chemical biology (2024) Vol. 31, Iss. 9, pp. 1688-1698
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top